Phase-controlled Synthesis of Molybdenum Oxide Nanoparticles for Surface Enhanced Raman Scattering and Photothermal Therapy

Yan Zhan,Yingliang Liu,Hongru Zu,Yanxian Guo,Shuangshuang Wu,Haiyao Yang,Zhiming Liu,Bingfu Lei,Jianle Zhuang,Xuejie Zhang,Di Huang,Chaofan Hu
DOI: https://doi.org/10.1039/c8nr00413g
IF: 6.7
2018-01-01
Nanoscale
Abstract:Different from their bulk counterparts, plasmonic molybdenum oxide nanomaterials display superior optical and electronic properties, but unfortunately, phase-controlled synthesis of molybdenum oxide nanomaterials with multifunctional performances still remains a challenge. To actualize this, a surfactant-free solvothermal strategy was proposed to fabricate molybdenum oxide nanomaterials with a tunable phase. Encouragingly, the as-prepared molybdenum dioxide nanoparticles (MoO2 NPs) exhibit intense near-infrared (NIR) absorption attributed to the localized surface plasmon resonance (LSPR) effect, which results in their application as a surface enhanced Raman scattering (SERS) substrate to detect trace amounts of molecular species including Rhodamine 6G (R6G), crystal violet (CV), IR-780 iodide (IR780) and methylene blue (MB). The detection limit was as low as 5 × 10-8 M and the maximum enhancement factor (EF) was up to 1.10 × 107, compared to other semiconductor nanostructures, the SERS sensitivity may be the best. Meanwhile, with the significant photothermal conversion efficiency up to 61.3%, the plasmonic MoO2 NPs could also be used as a photothermal therapy (PTT) agent for efficient photothermal ablation of cancer cells in vitro.
What problem does this paper attempt to address?